Figure 1.

(a) Comparison of the clinical outcome (estimated by means of TSUI-score) in ELISA-negative (open bar) and ELISA-positive patients. The difference is significant (p < 0.015). (b) Comparison of the mean unified dose used for the treatment of ELISA-negative (open bar) and ELISA-positive patients. The difference is highly significant (p < 0.001).
ELISA, enzyme-linked immunosorbent assay.